MedPath

An observational study to evaluate drug utilization pattern and adverse drug reaction profile in radiotherapy and oncology section.

Phase 4
Not yet recruiting
Conditions
Adverse drug reaction profile and drug utilization pattern in radiotherapy and oncology section.
Registration Number
CTRI/2016/11/007421
Lead Sponsor
Department of Pharmacology Government Medical College Bhavnagar
Brief Summary

The study is meant to determine ADRs due to anticancer regimens and to evaluate its causality , severity, preventability, and to study drug utilization pattern in patients attending day care oncology section.

Ø **Study Design**- Prospective,observational study.

Ø **Duration**- 24 months.

Ø **Methodology**- A prospective analysis of ADR ,drug utilization   pattern of medicines prescribed in the Oncology section  will be  done for 24 months after approval from Institutional Review Board.

a.     For drug utilization pattern all patients will get enrolled.

b.     The participant will be screened during the OPD hours and inwards for suspected ADRs thrice a week.

c.      Consent will be taken if any interventional investigation is done and in a case of children or illiterate people  consent will be taken from a guardian.

d.     All newly diagnosed patients or known cases of cancer,  any type and of  any age group and either gender (including      pregnant women) attending oncology section who will  be prescribed anti-cancer medications having ADR will be   included in the study.

e.      ADRs   noticed  by  the  principal  investigator  or assigned doctors , spontaneously  reported   by patients  or  their  guardian  based  on clinical examination and laboratory  findings  will  be  noted.

Ø **ADR’S** will be assessed according to

·        Causality assessment by  Naranjo  scale and WHO Scale.

·        Severity assessment will be done by (Modified Hartwig  and Siegel-1992)

·        Preventability  will be assessed by Modified Schumock and

         Thornton scale.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria
  • 1.All the participants undergoing chemotherapy in day care centre during the study time period will be enrolled.
  • 2.All participants receiving anti-cancer regimens, will be included in the study .
  • ï‚§3.Participants of any age group.
Exclusion Criteria

Patients not receiving any kind of cancer chemotherapy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
•To analyze drug utilization pattern.In morning OPD hours and in evening round ( 3days per week)for 2 year duration.
•To identify the ADR’s caused by anti-cancer drugsIn morning OPD hours and in evening round ( 3days per week)for 2 year duration.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Government Medical College and Sir Takhtsinhji General Hospital Bhavnagar

🇮🇳

Bhavnagar, GUJARAT, India

Government Medical College and Sir Takhtsinhji General Hospital Bhavnagar
🇮🇳Bhavnagar, GUJARAT, India
Dr Ruchika Kalra
Principal investigator
09772616565
drruchika@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.